Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Litvan

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
Neurology|November 1, 1996
Can tropicamide eye drop response differentiate patients with progressive supranuclear palsy and Alzheimer's disease from healthy control subjects?I Litvan, E J FitzGibbon
Advances in Neurology|July 20, 1999
Progressive supranuclear palsyI Litvan, A J Lees
Advances in Neurology|January 7, 2000
Neuropsychiatric aspects of corticobasal degenerationJ L Cummings, I Litvan
Archives of Neurology|May 30, 1998
Apolipoprotein E4 (epsilon) allele does not affect the onset or symptom severity in progressive supranuclear palsyI Litvan, A M Saunders
Minerva Medica|December 24, 2011
Mild cognitive impairment in Parkinson's diseaseJ G Goldman, I Litvan
Neurology|August 11, 1991
Progressive supranuclear palsy: altered sensory processing leads to degraded cognitionR Johnson, I Litvan, J Grafman
Brain and Cognition|August 1, 1995
Neuropsychological features of progressive supranuclear palsyJ Grafman, I Litvan, M Stark
Neuropsychologia|January 1, 1986
Does reversed laterality really exist in dextrals? A case studyC Junqué, I Litvan, P Vendrell
Neurology|July 11, 2001
Tau genotype: no effect on onset, symptom severity, or survival in progressive supranuclear palsyI Litvan, M Baker, M Hutton
Archives of Neurology|December 1, 1990
Effects of physostigmine on spatial attention in patients with progressive supranuclear palsyC Kertzman, D L Robinson, I Litvan
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
Neurology|November 1, 1996
Can tropicamide eye drop response differentiate patients with progressive supranuclear palsy and Alzheimer's disease from healthy control subjects?I Litvan, E J FitzGibbon
Advances in Neurology|July 20, 1999
Progressive supranuclear palsyI Litvan, A J Lees
Advances in Neurology|January 7, 2000
Neuropsychiatric aspects of corticobasal degenerationJ L Cummings, I Litvan
Archives of Neurology|May 30, 1998
Apolipoprotein E4 (epsilon) allele does not affect the onset or symptom severity in progressive supranuclear palsyI Litvan, A M Saunders
Minerva Medica|December 24, 2011
Mild cognitive impairment in Parkinson's diseaseJ G Goldman, I Litvan
Neurology|August 11, 1991
Progressive supranuclear palsy: altered sensory processing leads to degraded cognitionR Johnson, I Litvan, J Grafman
Brain and Cognition|August 1, 1995
Neuropsychological features of progressive supranuclear palsyJ Grafman, I Litvan, M Stark
Neuropsychologia|January 1, 1986
Does reversed laterality really exist in dextrals? A case studyC Junqué, I Litvan, P Vendrell
Neurology|July 11, 2001
Tau genotype: no effect on onset, symptom severity, or survival in progressive supranuclear palsyI Litvan, M Baker, M Hutton
Archives of Neurology|December 1, 1990
Effects of physostigmine on spatial attention in patients with progressive supranuclear palsyC Kertzman, D L Robinson, I Litvan
Pageof 13